|
|
Previous Article | Table of Contents | Next Article 
Protein S Tokushima: abnormal molecule with a substitution of Glu for
Lys-155 in the second epidermal growth factor-like domain of protein S
T Hayashi, J Nishioka, T Shigekiyo, S Saito and K Suzuki
Department of Molecular Biology on Genetic Disease, Mie University School
of Medicine, Tsu-city, Japan.
A 29-year-old female patient with heterozygous congenital protein S
deficiency suffering from thrombotic disease had normal levels of both
total and free protein S antigen (70% and 65%, respectively), but low
cofactor activity (31%) for activated protein C, indicating that she had a
variant of protein S, protein S Tokushima. Western blotting using the
polyclonal anti-protein S antibody showed that approximately half of the
patient's protein S appeared to be the variant with a higher molecular
weight than normal protein S. The partially purified variant protein S
bound neither to the monoclonal antibody recognizing calcium- dependent
conformation of protein S nor to the antibody recognizing the
thrombin-sensitive domain of protein S. Among the exons from II to XV of
the patient's protein S gene encoding from the NH2-terminal end to the
COOH-terminal end of protein S, only one missense mutation (A to G) was
found in exon VI of the protein S alpha-gene, which results in amino acid
substitution of Glu(GAG) for Lys-155(AAG) in the second epidermal growth
factor-like domain of protein S. The recombinant protein S Tokushima
expressed in BHK cells had a slightly higher molecular weight than the
recombinant normal one, did not bind to the antibody specific for the
thrombin-sensitive domain, and did not show the cofactor activity. These
findings suggest that the protein S Tokushima molecule is structurally and
functionally a variant of protein S, and that this variant protein S is the
cause of severe thrombosis in this patient.
Volume 83,
Issue 3,
pp. 683-690,
02/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Kimura, S. Honda, T. Kawasaki, H. Tsuji, S. Madoiwa, Y. Sakata, T. Kojima, M. Murata, K. Nishigami, M. Chiku, et al.
Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients
Blood,
February 15, 2006;
107(4):
1737 - 1738.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Rezende, R. E. Simmonds, and D. A. Lane
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex
Blood,
February 15, 2004;
103(4):
1192 - 1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Espinosa-Parrilla, T. Yamazaki, N. Sala, B. Dahlback, and P. G. de Frutos
Protein S secretion differences of missense mutants account for phenotypic heterogeneity
Blood,
January 1, 2000;
95(1):
173 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leroy-Matheron, M. Gouault-Heilmann, M. Aiach, and S. Gandrille
A Mutation of the Active Protein S Gene Leading to an EGF1-Lacking Protein in a Family With Qualitative (Type II) Deficiency
Blood,
June 15, 1998;
91(12):
4608 - 4615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Li and G. L. Long
Identification of Two Novel Point Mutations in the Human Protein S Gene Associated With Familial Protein S Deficiency and Thrombosis
Arterioscler. Thromb. Vasc. Biol.,
December 1, 1996;
16(12):
1407 - 1415.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Ohashi, K. Nagata, J. Toshima, T. Nakano, H. Arita, H. Tsuda, K. Suzuki, and K. Mizuno
Stimulation of Sky Receptor Tyrosine Kinase by the Product of Growth Arrest-specific Gene 6
J. Biol. Chem.,
September 29, 1995;
270(39):
22681 - 22684.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |